Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

U.S. Physical Therapy, Inc. (USPH)

NYSE Health Care Health Care Facilities S&P SmallCap 600
$99.49
+2.29 (+2.36%)
Close of Nov 06, 2026 · end-of-day data
Source: U.S. Physical Therapy, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$356.55M$414.05M$453.91M$481.97M$422.97M$495.02M$553.14M$604.80M$671.35M$780.99M
Gross profit$82.01M$90.62M$101.66M$112.47M$94.45M$117.18M$112.02M$121.51M$123.92M$149.69M
Selling, general & admin$32.48M$35.89M$41.35M$45.05M$42.04M$46.53M$46.11M$51.95M$58.29M$69.26M
Operating income$49.53M$54.73M$60.31M$67.42M$52.41M$70.65M$56.80M$50.51M$62.99M$86.68M
Interest expense$11.48M$21.06M$2.04M$2.08M——————
Pre-tax income$38.15M$33.76M$60.21M$70.91M$65.51M$73.20M$55.57M$49.38M$60.21M$77.81M
Income tax$11.88M$6.03M$11.37M$13.65M$13.02M$15.27M$12.16M$12.16M$14.61M$19.81M
Net income$20.55M$22.26M$34.87M$40.04M$35.19M$40.83M$32.16M$28.24M$31.42M$39.58M
EBITDA$58.31M$64.44M$70.07M$77.52M$62.95M$82.24M$71.54M$66.21M$81.67M$109.07M
EPS (basic)$1.64$1.76$1.31$2.45$2.48$2.41$2.25$1.28$1.84$1.42
EPS (diluted)$1.64$1.76$1.31$2.45$2.48$2.41$2.25$1.28$1.84$1.42
Diluted shares12.50M12.57M12.67M12.76M12.84M12.90M12.98M14.19M15.06M15.18M
Gross margin23.0%21.9%22.4%23.3%22.3%23.7%20.3%20.1%18.5%19.2%
Operating margin13.9%13.2%13.3%14.0%12.4%14.3%10.3%8.4%9.4%11.1%
Net margin5.8%5.4%7.7%8.3%8.3%8.2%5.8%4.7%4.7%5.1%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$20.05M$21.93M$23.37M$23.55M$32.92M$28.57M$31.59M$152.82M$41.36M$35.57M
Receivables$38.84M$44.71M$44.75M$46.23M$41.91M$46.27M$51.90M$51.80M$59.04M$64.25M
Total current assets$65.96M$77.08M$79.21M$85.39M$87.64M$95.17M$111.27M$233.38M$137.58M$139.99M
Goodwill$226.81M$271.34M$293.52M$317.68M$345.65M$434.68M$494.10M$509.57M$667.15M$692.39M
Total assets$351.23M$418.98M$443.17M$630.50M$594.36M$749.43M$858.15M$997.24M$1.17B$1.20B
Total current liabilities$24.62M$39.55M$41.95M$60.56M$93.49M$83.48M$85.49M$102.19M$116.28M$139.04M
Short-term debt$1.23M$4.04M$1.43M$728.00K$4.90M$830.00K$7.86M$7.69M$11.00M$9.87M
Long-term debt$50.60M$56.73M$38.40M$50.36M$16.60M$117.59M$175.83M$138.99M$142.53M$152.59M
Total debt$51.82M$60.77M$39.84M$51.09M$21.50M$118.42M$183.69M$146.68M$153.53M$162.46M
Total liabilities$162.54M$110.34M$92.35M$181.39M$184.39M$296.98M$373.59M$345.00M$408.42M$433.81M
Shareholders' equity$187.55M$204.87M$215.94M$240.26M$276.16M$295.61M$315.79M$476.19M$488.93M$476.43M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$51.05M$56.53M$73.00M$62.45M$100.00M$76.41M$58.54M$81.98M$74.94M$75.06M
Capital expenditures$8.26M$7.09M$7.19M$10.19M$7.64M$8.20M$8.25M$9.29M$9.19M$14.07M
Free cash flow$42.79M$49.43M$65.81M$52.26M$92.36M$68.20M$50.29M$72.68M$65.75M$60.99M
Investing cash flow-$32.49M-$43.58M-$23.91M-$37.99M-$51.20M-$124.14M-$81.27M-$45.02M-$149.45M-$36.71M
Financing cash flow-$14.29M-$11.06M-$47.66M-$24.27M-$39.42M$43.38M$25.76M$84.27M-$36.95M-$44.14M
Dividends paid$8.51M$10.07M$11.66M$14.55M$4.11M$18.77M$21.32M$24.13M$26.54M$27.36M
Share buybacks———————$0$0$5.57M
Stock-based compensation$4.96M$5.03M$5.94M$6.99M$7.92M$7.87M$7.26M$7.24M$7.82M$8.27M
Depreciation & amortization$8.78M$9.71M$9.76M$10.10M$10.53M$11.59M$14.74M$15.70M$18.68M$22.39M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.